HEPARIN SODIUM - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for heparin sodium and what is the scope of freedom to operate?

Heparin sodium is the generic ingredient in forty-one branded drugs marketed by Hospira, Intl Medication, Luitpold, Parke Davis, Smith And Nephew, Solopak, Abraxis Pharm, Aspen Global Inc, B Braun Medical Inc, Be Pharms, Casi Pharms Inc, Chamberlin Parenterl, Dell Labs, Dr Reddys, Epic Pharma Llc, Fresenius Kabi Usa, Gland, Hikma, Hospira Inc, Lilly, Mylan Labs Ltd, Nanjing King-friend, Pfizer, Pharm Spec, Pharmacia And Upjohn, Sagent Pharms, Sandoz, Shenzhen Techdow, Watson Labs Inc, Baxter Hlthcare, Mcgaw, B Braun, Pharma Serve Ny, 3M, and Cormedix, and is included in eighty-seven NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are forty-nine drug master file entries for heparin sodium. Twenty-two suppliers are listed for this compound.

Summary for HEPARIN SODIUM

US Patents:	4
Tradenames:	41
Applicants:	35
NDAs:	87
Drug Master File Entries:	49
Finished Product Suppliers / Packagers:	22
Clinical Trials:	98
Drug Prices:	Drug price trends for HEPARIN SODIUM
What excipients (inactive ingredients) are in HEPARIN SODIUM?	HEPARIN SODIUM excipients list
DailyMed Link:	HEPARIN SODIUM at DailyMed

See drug prices for HEPARIN SODIUM

Recent Clinical Trials for HEPARIN SODIUM

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Vaneltix Pharma, Inc.	Phase 2
Prevail Infoworks, Inc	Phase 2
The First Affiliated Hospital with Nanjing Medical University	N/A

See all HEPARIN SODIUM clinical trials

Pharmacology for HEPARIN SODIUM

Drug Class	Anti-coagulant Unfractionated Heparin

Anatomical Therapeutic Chemical (ATC) Classes for HEPARIN SODIUM

US Patents and Regulatory Information for HEPARIN SODIUM

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hospira Inc	HEPARIN SODIUM	heparin sodium	INJECTABLE;INJECTION	090571-003	Aug 31, 2009	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Cormedix	DEFENCATH	heparin sodium; taurolidine	SOLUTION;N/A	214520-001	Nov 15, 2023		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Luitpold	HEPARIN SODIUM	heparin sodium	INJECTABLE;INJECTION	087452-001	Oct 31, 1983		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.